Covid-19

Plant stanols increase COVID-19 antibody response in the overweight

08-Mar-2024 By Claudia Adrien

Overweight and obese individuals who consumed plant stanols decreased the overall inflammatory activity of the immune system while simultaneously increasing antibody responses to COVID-19, according to a study published in the American Journal of Clinical...

Are omega-3s associated with fewer post-COVID-19 mental health conditions?

12-Feb-2024 By Danielle Masterson

A retrospective study found that the use of omega-3s was associated with a lower risk for depression, anxiety and insomnia related to the diagnosis of COVID-19.

Study: Probiotic improves symptoms of allergic rhinitis in four weeks

17-Jan-2024 By Olivia Haslam

A probiotic supplement designed to increase immune response to the Covid-19 vaccine is effective against allergic rhinitis symptoms such as itching, sneezing and tearing, according to new research.

Probiotics may thwart symptoms of Covid-19

12-Jan-2024 By Claudia Adrien

Commercially available probiotics may limit the symptoms of Covid-19, such as preventing the development of upper and lower respiratory tract infections in healthy adults, according to a study by Duke University researchers.

Synbiotic supplementation may ease long COVID: RCT

05-Jan-2024 By Stephen Daniells

Supplementation with a prebiotic-probiotic combination may help with some long COVID problems such as fatigue, memory, concentration and gastrointestinal upset, says a new large study from Hong Kong.

Research suggests Covid-19 pandemic increased ‘dangerous’ supplement use in overweight women

05-Dec-2023 By Claudia Adrien

The Covid-19 pandemic may have heightened women’s concerns around health and body weight, thereby increasing that population’s risk of using supplements considered dangerous by researchers, according to findings in Social Science and Medicine.

Study sheds light on disruptions to infant gut microbiome from COVID-19 pandemic

25-Aug-2023 By Stephen Daniells

Dramatic environmental changes during the early COVID-19 pandemic have disrupted the development and diversity of the infant gut microbiome, according to data collected from infants living in New York City.

Vitamin D improves outcomes of hospitalised COVID-19 patients

02-Aug-2023 By Olivia Brown

A new study finds that supplementation with 25(OH) vitamin D in an Italian cohort of hospitalised COVID-19 patients that were deficient, resulted in a reduced length of hospital stay compared to those who were not supplemented.

COVID:19: L-carnitine supplement may have protective effect

26-Jul-2023 By Olivia Brown

A new RCT has found that the L-carnitine supplement Carnipure tartrate can increase platelet counts in patients testing positive for COVID-19, suggesting it may have a protective effect against thrombosis-induced complications.

Probiotic may boost Covid-19 antibody response in healthy adults: RCT

14-Jul-2023 By Stephen Daniells

BioGaia Protectis (L. reuteri DSM 17938) may increase the anti-SARS-CoV-2 antibody response upon infection in healthy adults, according to a randomised, triple-blinded, placebo-controlled study.

Antivirals: the “promising” potentials of microbiome-targeted functional foods

08-Jun-2023 By Olivia Brown

A new review has noted the significant dysbiosis and loss of microbial diversity occurring in COVID-19 patients, highlighting the potentials for targetted probiotic dietary interventions.

Covid complications: synbiotic may lower risk of adverse outcomes in the vulnerable

27-Apr-2023 By Olivia Brown

The new RTC in elderly and type 2 diabetic individuals finds that in the group administered a SIM01 synbiotic formulation, there were significantly less reported adverse health outcomes.

Study spotlight supplements found to reduce side effects of COVID-19 vaccines

13-Apr-2023 By Olivia Brown

The new study observes a significant association between supplement consumption and vaccination side effects in an Italian adult population, specifically spotlighting the effects of omega-3 and mineral supplement consumption in reducing associated adverse...

High omega-3 blood levels may reduce the severity of COVID-19

02-Mar-2023 By Asia Sherman

Increased consumption of oily fish and the use of omega-3 fatty acid supplements may reduce the risk of adverse COVID-19 outcomes, according to new research from the Fatty Acid Research Institute (FARI).

Global review spotlights most widely used supplements during Covid-19

14-Feb-2023 By Olivia Brown

Vitamin C, D and Zinc were the most widely reported supplements used during COVID, whilst natural/herbal products including ginger and honey were also popular, a new systematic review concludes.

iHerb releases wellness trend predictions for 2023

23-Jan-2023 By Danielle Masterson

The report unpacks what’s in store for dietary supplements and natural products, underscoring how consumer needs will change over the coming year.

The hits keep coming on the CBD COVID claims jukebox

13-Jan-2023 By Hank Schultz

Despite President Biden infamously declaring that the COVID-19 pandemic is over, there is no shortage of CBD companies claiming to cure or treat the disease, as a glance at the latest warning letters shows.

FTC seeks injunction against marketer of vitamin/mineral supplement

05-Dec-2022 By Hank Schultz

The Federal Trade Commission has filed a request for a permanent injunction against a dietary supplement marketer that allegedly made repeated claims to treat COVID-19 via a vitamin/mineral product.

Review supports zinc’s anti-viral activity, potential for COVID-19

27-Sep-2022 By Nicola Gordon-Seymour

Zinc is an essential trace mineral involved in modulating human immune responses and may prove to be an important therapeutic agent for viral infections, such as COVID-19, say the authors of a recent review.

PEA may improve outcomes for Covid-19: Study

19-Sep-2022 By Nicola Gordon-Seymour

Palmitoylethanolamide (PEA) may reduce inflammation and optimise immune responses to infectious conditions such as Covid-19, according to researchers in the USA.

BMJ studies that discount vitamin D in COVID fight draw ire

12-Sep-2022 By Danielle Masterson

Researchers and stakeholders are reacting to new research that contradicts two previous meta-analyses of randomized clinical trials that found vitamin D to have a protective shield against respiratory illnesses.

Study adds credibility of antiviral effects of echinacea extract in relation to Covid-19

19-Aug-2022 By Nicola Gordon-Seymour

A standardised extract of Echinacea purpurea is an efficient and cost-effective antiviral counter measure to vaccination in the prevention of respiratory tract infections (RTIs) and for reducing concomitant viral loads, say scientists.

Vitamin D & Me moved the needle on connecting consumers with nutrition research

17-Aug-2022 By Hank Schultz

Connecting consumers with science was the basic idea behind the Vitamin D & Me project, which won this year’s Industry Initiative of the Year in NutraIngredient-USA’s annual awards.

Resveratrol cuts hospitalization rate for COVID outpatients

01-Jul-2022 By Hank Schultz

A pilot study has found that resveratrol in combination with vitamin D3 lowered the rate of hospitalization among a cohort of subjects who tested positive for COVD-19.

Multi-component supplement may help post-COVID fatigue recovery: Data

13-Jun-2022 By Stephen Daniells

A combination of amino acids, B vitamins, and other bioactives may improve muscle and physical performance measures for people with persistent fatigue post-COVID infection, says a new study from Italy.

Nutracast: The van Breemen Company launches following groundbreaking hemp study

10-Jun-2022 By Danielle Masterson

Lead scientist Richard van Breemen, along with his co-founder and CEO Jacob Crabtree joined us to discuss the research that caught the world’s attention.

Renewed lockdowns in China creating many short- and long-term effects

17-May-2022 By Hank Schultz

Renewed lockdowns in China has thrown another wrench into the global supply of botanical ingredients. But having graduated from the recent school of hard knocks, suppliers are managing to cope, experts said.

Emergen-C adds ashwagandha and apple cider vinegar to portfolio

26-Apr-2022 By Danielle Masterson

In order to keep up with consumer demand for immune health, Emergen-C recently added two new extensions to the brand's botanical line of gummy and powder dietary supplements.

FDA, FTC slap seven CBD firms with COVID-19 warning letters

01-Apr-2022 By Hank Schultz

Seven marketers of CBD products received warning letters for making COVID-19 treatment claims as part of the ongoing joint FDA/FTC enforcement action.

Measuring psychological stress in health research

17-Mar-2022 By Danielle Masterson

Between the pandemic, inflation rates, global issues and more, an increasing number of consumers are turning to supplements to support their mental health. According to SPINS, vitamins & supplements for stress relief and sleep support products saw...

Immunity, analytical advances, and sleep: Themes and first speakers announced for IPA World Congress + Probiota Americas

23-Feb-2022 By Stephen Daniells

Delegate registration is now open for the IPA World Congress + Probiota Americas in Washington DC, with speakers already for a blockbuster opening session on microbiome modulation to boost immunity and improve COVID outcomes.

Nutrition Asia

‘A habit sticks’: P&G and Holista Colltech on why immune product demand will persist - WATCH

23-Feb-2022 By Tingmin Koe

The COVID-19 has led to new habits that are here to stay, including taking supplements that benefit the immune system, according to P&G and Holista Colltech.

Usana sales, share price tumbles over pandemic disruption

10-Feb-2022 By Hank Schultz

Multi level marketing firm Usana absorbed a significant blow from the global spike in COVID-19 infections in late 2021 as it recorded a 14% decline in sales in its fourth quarter earnings report.

Nagasaki University and Kirin to study lactic acid bacteria on relieving symptoms in COVID-19 patients

18-Jan-2022 By Guan Yu Lim

Nagasaki University and Kirin Holdings are embarking on a joint clinical research to assess the effect of lactic acid bacteria on relieving symptoms in COVID-19 human subjects.

Probiotic combination may positively affect outcomes in COVID-19 outpatients

12-Jan-2022 By Stephen Daniells

A combination of four probiotic strains may reduce viral load and remission rates in COVID-19 outpatients with mild symptoms, says a new study from Mexico.

Probiotic may boost immune response to COVID-19 vaccine in the elderly

10-Jan-2022 By Stephen Daniells

Probiotic supplementation may enhance the immune response to COVID-19 vaccines in elderly nursing home residents, says a new study from Europe.

Federal court agrees to consent decree with NJ defendants over ‘Nano Silver’ products touted as COVID treatment

03-Jan-2022 By Stephen Daniells

New Jersey-based Natural Solutions Foundation has been permanently banned from distributing unapproved and misbranded products touted as COVID-19 treatments.

NutraIngredients-USA’s Top 10 most read articles of 2021

23-Dec-2021 By Stephen Daniells

As the year draws to a close, we thought it would be worthwhile to review the most read articles, with NAC, FDA kratom seizures, vitamin D benefits, and Elysium Health making the top 10.

Report finds immunity supporting foods and supplement adoption boosted by pandemic fears

03-Dec-2021 By Will Chu

A report by The Global Wellness Economy (GWI) identifies an upsurge in immunity-focused food consumption and supplement use, buoyed on by ongoing health disruptions caused by COVID-19.

Pandemic-induced demand created field of dreams for adulterators, Blumenthal warns

08-Nov-2021 By Hank Schultz

The demand spike caused by the global pandemic has been a bonanza for the botanical supplements industry. But ABC chief Mark Blumenthal says it has been the biggest threat of adulteration during his time in the industry, too.

Meta-analyses: Higher vitamin D levels linked to lower COVID-19 rates

04-Nov-2021 By Danielle Masterson

Overwhelming evidence suggests a link between higher vitamin D levels and lower incidence and severity of COVID-19.

Trend tracker: Microbiome research, alternative protein, consumers' health habits in focus

29-Oct-2021 By Tingmin Koe

This industry trends round-up will shine the spotlight on microbiome research, alternative protein, and consumers' health and supplement intake habits amid the ongoing pandemic.

Pandemic put wind in sails of personalized nutrition

14-Oct-2021 By Hank Schultz

The pandemic has supported the growth of personalized nutrition companies, though that trend has not been as obvious as some, like the increased demand for immunity products.

Sports nutrition takes on the personalisation theme as market evolves

12-Oct-2021 By Will Chu

Personalised Nutrition (PN) offers opportunities both for performance and active sports nutrition, according to FMCG Gurus’ Head of Research & Insight, Mike Hughes but affordability remains a sticking issue.

Port snarl in China shows shipping crisis far from over

27-Aug-2021 By Hank Schultz

The global shipping crisis brought on by the pandemic is continuing to strain supply chains and raise costs, a number of companies have told NutraIngredients-USA.

HR exec: ‘In 20+ years, I’ve never experienced a labor market as fluid & as unpredictable as the current market’

12-Jul-2021 By Stephen Daniells

As the US economy surges back, many industries are bracing themselves for a tsunami of employee turnover. In the first of our two articles on the changing HR landscape, NutraIngredients-USA explores the challenges of staff retention and how the dietary...

Faecal microbiota transplants may influence COVID-19 severity, suggest researchers

09-Jul-2021 By Will Chu

Tweaking the gut microbiome via a faecal microbiome transplant (FMT) may be worth further study as an approach to regulate the immune system in COVID-19 patients, researchers speculate.

Attorney on FTC's plan to stop COVID-19-related scams

28-Jun-2021 By Danielle Masterson

Following Probiotas Americas, NutraIngredients-USA sat down with Attorney Ivan Wasserman to hear what is going on in the legal world of dietary supplements.

Nuherbs VP: Shipping issues unlikely to work themselves out until April 2022

24-Jun-2021 By Stephen Daniells

With over 80% of global trade transported by sea, ongoing issues and bottlenecks in global shipping will continue to impact international raw material and ingredients supplies, which could drag into Spring of 2022, says Wilson Lau, VP of Nuherbs.

Study finds low vitamin K status predictive of COVID-19 mortality

17-Jun-2021 By Nikki Hancocks

A new study, supported by Kappa Bioscience, confirms that vitamin K status is lower in hospitalised patients with COVID-19 and finds low vitamin K status to be predictive of higher mortality.